STAT+: Pump the brakes on AI, buddy; and deposition deadlock

STAT PlusNewsletterHealth Care Inc. Newsletter Pump the brakes on AI, buddy; and deposition deadlock You’re reading STAT’s Health Care Inc. newsletter Manage alerts for this article Email this article Share this article By Bob HermanMay 4, 2026 Business of Health Care Reporter Bob Herman[email protected]Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09. This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here. Hey! Are you going to be in Washington, D.C. on May 19? I’ll be moderating a Georgetown University panel discussion on vertical integration in health care. Jonathan Kanter, the former top antitrust official at the Department of Justice, also will make remarks. It’s gonna be lit. Reserve a spot here. And as always, a penny for your thoughts: [email protected].Advertisement The Elevance exec you need to know Lawsuits alleging health insurers defrauded Medicare and other government programs take forever to litigate. Maybe they’re more about the friends you make along the way. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in Monthly $39 Totals $468 per year $39/month Get Started Totals $468 per year Starter $30 for 3 months, then $399/year $30 for 3 months Get Started Then $399/year Annual $399 Save 15% $399/year Get Started Save 15% 11+ Users Custom Savings start at 25%! Request A Quote Request A Quote Savings start at 25%! 2-10 Users $300 Annually per user $300/year Get Started $300 Annually per user View All Plans To read the rest of this story subscribe to STAT+. Subscribe Log In Artificial intelligence, Congress, drug development, government agencies, Health insurance, insurance, legal, Policy, STAT+ Submit a correction requestReprints Bob Herman Business of Health Care Reporter Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences those businesses and shapes what we all pay for care. He is also the author of the Health Care Inc. newsletter. You can reach Bob on Signal at bobjherman.09. Newsletter Unpacking the business — and secretive inner workings — of the U.S. health care industry Recommended The Readout May 4, 2026 UCB to acquire maker of antibody treatments for autoimmune diseases The Readout May 1, 2026 STAT Plus: Axsome wins FDA nod for Alzheimer’s agitation Advertisement Pharmalot April 30, 2026 STAT Plus: FDA wants to exclude weight loss drugs from a compounding list The Readout April 30, 2026 STAT Plus: Five-way obesity drug is super effective — in mice Insurance April 30, 2026 STAT Plus: DOJ, Elevance spar over access to top exec in Medicare Advantage fraud case Subscriber Picks